Patent · US Active

Pharmaceutical composition, methods for treating and uses thereof

US11918596B2 · kind B2 · utility

0Cited by

77References

12Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Uli Christian BROEDL · Oakville, CA
Odd-Erik JOHANSEN · Måløy, NO
Gabriel Woojai KIM · Petersau, DE
Eric Williams MAYOUX · Gambais, FR
Afshin SALSALI · Princeton, US
Nima SOLEYMANLOU · Sherwood Park, CA
Maximilian von EYNATTEN · Wiesbaden, DE
Hans-Juergen WOERLE · Munich, DE
David Z.I. CHERNEY · Toronto, CA
Bruce A. PERKINS · Toronto, CA
Andreas DAIBER · Scheeßel, DE
Thomas MUENZEL · Mainz, DE

Key dates

Filing date	Jul 21, 2021
Grant date	Mar 5, 2024
Priority date	—
Expiry date	Feb 9, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing oxidative stress, for example in patients with type 1 or type 2 diabetes, as well as to the use of such SGLT-2 inhibitors in treatment and/or prevention of cardiovascular diseases in patients, for example type 1 or type 2 diabetes patients. The present invention further relates to certain SGLT-2 inhibitors for treating and/or preventing a metabolic disorder and preventing, reducing the risk of or delaying the occurrence of a cardiovascular event in patients, for example patients with type 1 or type 2 diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.